中文名 | AMG-3969 |
英文名 | AMG-3969 |
别名 | 化合物AMG-3969 AMG-3969游离态 4-[(2S)-4-[(6-氨基-3-吡啶基)磺酰基]-2-(1-丙炔-1-基)-1-哌嗪基]-Α,Α-双(三氟甲基)-苯甲醇 (S)-2-(4-(4-((6-氨基吡啶-3-基)磺酰基)-2-(丙-1-炔-1-基)哌嗪-1-基)苯基)-1,1,1,3,3-六氟丙烷-2-醇 |
英文别名 | CS-2503 AMG3969 AMG-3969 AMG 3969 Benzenemethanol, 4-[(2S)-4-[(6-amino-3-pyridinyl)sulfonyl]-2-(1-propyn-1-yl)-1-piperazinyl]-α,α-bis(trifluoromethyl)- (S)-2-(4-(4-((6-Aminopyridin-3-yl)sulfonyl)-2-(prop-1-yn-1-yl)piperazin-1-yl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol |
CAS | 1361224-53-4 |
化学式 | C21H20F6N4O3S |
分子量 | 522.46 |
密度 | 1.56±0.1 g/cm3(Predicted) |
沸点 | 648.8±65.0 °C(Predicted) |
溶解度 | 溶于DMSO |
酸度系数 | 10.12±0.15(Predicted) |
存储条件 | 2-8°C(protect from light) |
体外研究 | AMG-3969 exhibits potent cellular activity with an EC 50 of 0.202 μM and IC 50 of 4 nM, . It potently reverses the inhibitory effect of GKRP on GK activity and promotes GK translocation in vitro (isolated hepatocytes). |
体内研究 | AMG-3969 has good in vivo pharmacokinetic (PK) properties in rats (75%) and significantly lowers blood glucose levels in a dose-dependent manner db/db mice. AMG-3969 (100 mg/kg) demonstrates significant reductions in blood glucose with robust efficacy (56% reduction) observed at the 8 h time point. AMG-3969 demonstrates dose-dependent efficacy in three models of diabetes: diet induced obese (DIO), ob/ob and db/db mice; however,AMG-3969 is ineffective in lowering blood glucose in normoglycaemic C57BL/6 (B6) mice. AMG-3969 is highly effective in promoting carbohydrate substrate. AMG-3969 exhibits extended changes to carbohydrate oxidation as observed by increased respiratory exchange ratio into the next night and day after a single dose. |
参考资料 展开查看 | 1: Bourbeau MP, Ashton KS, Yan J, St Jean DJ Jr. Nonracemic synthesis of GK-GKRP disruptor AMG-3969. J Org Chem. 2014 Apr 18;79(8):3684-7. doi: 10.1021/jo500336e. Epub 2014 Apr 10. PubMed PMID: 24678849. 2: Nishimura N, Norman MH, Liu L, Yang KC, Ashton KS, Bartberger MD, Chmait S, Chen J, Cupples R, Fotsch C, Helmering J, Jordan SR, Kunz RK, Pennington LD, Poon SF, Siegmund A, Sivits G, Lloyd DJ, Hale C, St Jean DJ Jr. Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine series. J Med Chem. 2014 Apr 10;57(7):3094-116. doi: 10.1021/jm5000497. Epub 2014 Mar 31. PubMed PMID: 24611879. 3: St Jean DJ Jr, Ashton KS, Bartberger MD, Chen J, Chmait S, Cupples R, Galbreath E, Helmering J, Hong FT, Jordan SR, Liu L, Kunz RK, Michelsen K, Nishimura N, Pennington LD, Poon SF, Reid D, Sivits G, Stec MM, Tadesse S, Tamayo N, Van G, Yang KC, Zhang J, Norman MH, Fotsch C, Lloyd DJ, Hale C. Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles. J Med Chem. 2014 Jan 23;57(2):325-38. doi: 10.1021/jm4016747. Epub 2014 Jan 9. PubMed PMID: 24405213. 4: Lloyd DJ, St Jean DJ Jr, Kurzeja RJ, Wahl RC, Michelsen K, Cupples R, Chen M, Wu J, Sivits G, Helmering J, Komorowski R, Ashton KS, Pennington LD, Fotsch C, Vazir M, Chen K, Chmait S, |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.914 ml | 9.57 ml | 19.14 ml |
5 mM | 0.383 ml | 1.914 ml | 3.828 ml |
10 mM | 0.191 ml | 0.957 ml | 1.914 ml |
5 mM | 0.038 ml | 0.191 ml | 0.383 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!